1. Show article details.

    Varian Names Chief Medical Officer for Interventional Oncology

    PR Newswire – 10:00 AM ET 09/16/2019

    PALO ALTO, Calif. Dr. Facchini was most recently chief medical officer and head of medical affairs for BTG Plc. where he had responsibility for developing and commercializing products targeting critical care, cancer, vascular and other disorders. "Frank will be a great addition to the Varian Medical Affairs team," said Khuntia.

  2. Show article details.

    Varian Ranked Highest in Survey of US Radiation Oncology Professionals

    PR Newswire – 8:30 AM ET 09/16/2019

    PALO ALTO, Calif. "This annual survey is very important to us because it is direct feedback from our customers," said Chris Toth, president Varian Oncology Systems.

  3. Show article details.

    Varian Announces Multi-room Configuration for ProBeam 360 Proton Therapy System

    PR Newswire – 8:00 AM ET 09/16/2019

    PALO ALTO, Calif. The ProBeam 360° system in a multi-room configuration allows cancer centers to tailor the system to meet their clinical, research, and capacity needs.

  4. Show article details.

    Varian Unveils Innovative New Solution for Adaptive Therapy

    PR Newswire – 11:25 AM ET 09/15/2019

    PALO ALTO, Calif. Adaptive therapy provides the ability to alter the treatment plan based on tumor and anatomical changes. The streamlined workflow of Ethos therapy is enabled by its AI-driven planning and contouring capabilities. Ethos therapy offers the use of multimodality images, and daily iterative CBCT images at the console.

  5. Show article details.

    Stocks to Watch: PG&E, General Electric, Broadcom, Gap and More

    DJ Business News – 9:48 AM ET 09/13/2019

    Here are some of the companies with shares expected to trade actively in Friday's session. Stock movements noted by ticker reflect movements during regular trading hours; premarket trading is specified separately. PG&E (PCG): Up 8.91% premarket: PG&E (PCG) agreed on an $11 billion settlement to resolve the majority of claims by insurance carriers from the 2017 Northern California wildfires and the 2018 Camp Fire.

  6. Show article details.

    BRIEF-Varian And Oncora Partner To Accelerate Precision Medicine In Radiation Oncology

    Reuters – 8:39 AM ET 09/13/2019

    Varian Medical Systems Inc (VAR): * Varian Medical Systems Inc (VAR) - * VARIAN AND ONCORA PARTNER TO ACCELERATE PRECISION MEDICINE IN RADIATION ONCOLOGY Source text for Eikon: Further company coverage:

  7. Show article details.

    Varian and Oncora Partner to Accelerate Precision Medicine in Radiation Oncology

    PR Newswire – 8:15 AM ET 09/13/2019

    PALO ALTO, Calif. and PHILADELPHIA, Sept. 13, 2019  Varian today announced it is investing in Oncora Medical and partnering to accelerate the development of software tools to enable precision medicine in radiation oncology.

  8. Show article details.

    Varian Announces Fourth Quarter Fiscal Year 2019 Earnings Release Date

    PR Newswire – 4:05 PM ET 09/12/2019

    PALO ALTO, Calif. The Company will report results for the fourth quarter of fiscal year 2019 after market close on Wednesday, October 23, 2019.  The news release will be followed by a teleconference available to all interested at 1:30 p.m. Pacific Time.

  9. Show article details.

    BRIEF-Varian Expects To Benefit From Linear Accelerator Tariff Exclusion In China

    Reuters – 5:00 PM ET 09/11/2019

    Varian Medical Systems Inc (VAR): * VARIAN EXPECTS TO BENEFIT FROM LINEAR ACCELERATOR TARIFF EXCLUSION IN CHINA. * Varian Medical Systems Inc (VAR) - EXPECTS TO BE ELIGIBLE FOR A REFUND FROM TARIFFS THAT HAVE BEEN LEVIED SINCE ADDITIONAL TARIFFS WERE IMPLEMENTED. * VARIAN MEDICAL (VAR) - RECEIVED NOTICE FROM CHINA THAT MEDICAL LINEAR ACCELERATORS ARE EXCLUDED FROM ADDITIONAL TARIFFS CHINA IMPOSED ON U.S. PRODUCTS.

  10. Show article details.

    Varian Expects to Benefit from Linear Accelerator Tariff Exclusion in China

    PR Newswire – 4:44 PM ET 09/11/2019

    PALO ALTO, Calif. and BEIJING, Sept. 11, 2019  Varian has received notice from the Customs Tariff Commission of the State Council of China that medical linear accelerators are excluded from the additional tariffs China imposed on US products that began on August 23, 2018.

  11. Show article details.

    Varian-equipped New York Proton Therapy Center Treats First Patients

    PR Newswire – 9:05 AM ET 09/10/2019

    PALO ALTO, Calif. NYPC is expected to treat 1,400 patients annually, including most children in New York City with solid tumors, delivering the most advanced form of cancer radiation treatment currently available.

  12. Show article details.

    Cyclotron for Varian ProBeam Compact Proton Therapy System Installed at Sylvester Comprehensive Cancer Center

    PR Newswire – 8:15 AM ET 08/28/2019

    PALO ALTO, Calif. Proton therapy is an advanced form of cancer care. The full-featured ProBeam Compact system includes the cyclotron, Varian's unique pencil-beam scanning technology for intensity modulated proton therapy, a fully rotational gantry, robotic patient positioning tools, and a comprehensive suite of motion management tools.

  13. Show article details.

    BRIEF-Dr. Phil Febbo Named To Varian Board Of Directors

    Reuters – 4:28 PM ET 08/21/2019

    Varian Medical Systems Inc (VAR): * DR. PHIL FEBBO NAMED TO VARIAN BOARD OF DIRECTORS. * VARIAN MEDICAL SYSTEMS (VAR) - PHIL FEBB CHIEF MEDICAL OFFICER AT ILLUMINA HAS BEEN APPOINTED TO VARIAN BOARD, EFFECTIVE AUGUST 16 Source text for Eikon: Further company coverage:

  14. Show article details.

    Dr. Phil Febbo Named to Varian Board of Directors

    PR Newswire – 4:15 PM ET 08/21/2019

    PALO ALTO, Calif. "We are proud to have Phil Febbo join the Varian Board," said R. Andrew Eckert, chairman of Varian's Board of Directors. "Varian is a leader in addressing the global cancer challenge by developing innovative solutions that are increasing access to high quality care," said Febbo.

  15. Show article details.

    Varian Completes Purchase of Embolic Bead Asset

    PR Newswire – 4:05 PM ET 08/21/2019

    PALO ALTO, Calif. About Varian At Varian, we envision a world without fear of cancer. Press ContactMark PlungyDirector, Global Public Relations+1 424-5630 mark.plungy@varian.com. Investor Relations ContactJ.

  16. Show article details.

    Varian to Hold Investor Day in New York City

    PR Newswire – 8:15 AM ET 08/19/2019

    PALO ALTO, Calif. Varian will outline its growth initiatives in radiation oncology, interventional oncology, and more broadly across cancer care driven by its 'Intelligent Cancer Care' approach, the next wave of progress in oncology that harnesses advanced technologies like artificial intelligence, machine learning, and data analytics to ensure coordination and connectivity at every point of care.

  17. Show article details.

    BRIEF-Boston Scientific Says Submitted Borrowing Request For $2 Bln To Be Funded On Aug 19

    Reuters – 6:47 AM ET 08/19/2019

    Boston Scientific Corp (BSX): * BOSTON SCIENTIFIC (BSX) - SUBMITTED BORROWING REQUEST FOR $2.0 BILLION TO BE FUNDED ON AUG 19. * Boston Scientific Corp (BSX) - FUNDS FROM DRAWDOWN WILL BE USED TO PARTIALLY FINANCE BOSTON SCIENTIFIC'S ACQUISITION OF BTG PLC. * BOSTON SCIENTIFIC (BSX) - BORROWINGS UNDER TWO-YEAR DELAYED DRAW TERM LOAN CREDIT FACILITY WILL MATURE TWO YEARS FROM DATE OF CLOSING OF BTG ACQUISITION.

  18. Show article details.

    Varian Updates Investors on Proposed Reimbursement Changes

    PR Newswire – 4:05 PM ET 08/08/2019

    PALO ALTO, Calif. About Varian At Varian, we envision a world without fear of cancer. Forward-Looking Statements Except for historical information, this news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.

  19. Show article details.

    Varian to Host Investor Meeting at ASTRO in Chicago

    PR Newswire – 8:15 AM ET 08/08/2019

    PALO ALTO, Calif. Information about the webcast of the company's presentation will be available through a link on the company website at www.varian.com/investors. To attend Varian's ASTRO investor meeting, please RSVP to Katie Glenn at katie.glenn@varian.com by August 23, 2019.

  20. Show article details.

    BRIEF-Varian Announces Immaterial Impact Of Newly Proposed Tariffs

    Reuters – 8:27 AM ET 08/05/2019

    Varian Medical Systems Inc (VAR): * VARIAN ANNOUNCES IMMATERIAL IMPACT OF NEWLY PROPOSED TARIFFS. * VARIAN MEDICAL SYSTEMS (VAR) - ESTIMATES NEWLY PROPOSED TARIFFS BY U.S. ON REMAINING CHINESE IMPORTS SHOULD HAVE IMMATERIAL FINANCIAL IMPACT Source text for Eikon: Further company coverage:

Page:

Today's and Upcoming Events

  • Oct
    23

    VAR to announce Q4 earnings (Confirmed)

Past Events (last 90 days)

  • Jul
    24

    VAR announced Q3 earnings.

Data provided by Thomson Reuters © 2019

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.

462499.6.0
See the Latest Features
Personalized
Get relevant information about your holdings right when you need it.
See Your Performance Click the portfolio icon to get information about stocks you own without leaving the research page.
Faster Access to Positions A shortcut to view the full list of positions in your portfolio? Yes, please! Use the ticker search box.
Add Your Own Notes Use Notebook to save your investment ideas in one convenient, private, and secure place.
Convenient For You
Research that's clear, accessible, and all in one place makes for a better experience.
One-Stop Shop See everything you need to make investment decisions right in the dashboard.
Access Anywhere No matter where you are, use the Stock Research experience across multiple devices.
New Ideas, On the Ready Find new ideas using quick links to the Stock Screener.
New Ways to Research
Discover new tools to add or diversify your existing research strategy.
StockTwits Read live tweets from the financial and investing community about the stock you're interested in.
Fundamental Analysis Save time on research by getting an overall assessment of a company's valuation, quality, growth stability, and financial health.
Recognia Technical Analysis Perfect for the technical trader—this indicator captures a stock's technical events and converts them into short, medium, and long-term sentiment.
Top Competitors See how a stock measures up by instantly comparing it to the industry average and its top four competitors.
Social Sentiment Get a sense of people's overall feelings towards a company in social media with this summary tool.
Earnings Data Monitor earnings expectations over the past three quarters and model a stock's price based on its P/E.